Charming Medical Limited Class A Ordinary Shares (MCTA) P/E Ratio History
Insufficient DataInsufficient historical P/E data to classify valuation. · Data 2026–2026
Loading P/E history...
P/E Ratio Analysis
Compared to the Healthcare sector median P/E of 23.0x, MCTA trades at a 1701% premium to its sector peers. The sector includes 231 companies with P/E ratios ranging from 0.0x to 191.4x.
Relative to the broader market, MCTA commands a significant premium over the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our MCTA DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
MCTA Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
MCTA P/E vs Peers
Virtual and consumer health clinics peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $7B | 76.3 | 2.15Best | -10% | |
| $108M | 25.9 | 6.06 | +16%Best | |
| $104B | 21.7Lowest | 3.10 | +3% | |
| $127B | 39.6 | 2.66 | +8% | |
| $52B | 49.6 | 7.01 | -74% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
10-year return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
MCTA — Frequently Asked Questions
Quick answers to the most common questions about buying MCTA stock.
What is MCTA's P/E ratio?
Charming Medical Limited Class A Ordinary Shares (MCTA) trailing twelve-month P/E ratio is 414.5x, based on TTM diluted EPS of N/A. The 5-year average P/E is N/A and the historical range spans N/A to N/A.
Is MCTA stock overvalued or undervalued?
MCTA current P/E: 414.5x. 5-year average P/E: N/A. Percentile: N/A.
Is MCTA stock expensive?
MCTA is fairly valued relative to its own history. The current P/E of 414.5x is near the 5-year average of N/A (N/A percentile of historical range).
What is MCTA's historical P/E range?
Over the past 5 years, MCTA's P/E ratio has ranged from N/A to N/A, with a median of N/A and an average of N/A. The current P/E of 414.5x places the stock at the N/A percentile of this range. Full historical data spans 2026–2026.
How does MCTA's P/E compare to the S&P 500?
MCTA trades at 414.5x P/E versus the S&P 500 median of 25.3x. The 1538% premium to the market typically reflects higher expected earnings growth or quality.
How does MCTA's valuation compare to Healthcare peers?
Charming Medical Limited Class A Ordinary Shares P/E of 414.5x compares to the Healthcare sector median of 23.0x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is MCTA's PEG ratio?
MCTA PEG ratio is N/A, based on a P/E of 414.5x and EPS growth of 54.2%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is MCTA's earnings yield?
MCTA earnings yield is 0.24%, the inverse of its 414.5x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.